SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-10-000019
Filing Date
2010-08-09
Accepted
2010-08-09 17:17:09
Documents
10
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q form10q063010.htm 10-Q 601076
2 EXHIBIT 31.1 exhibit31.htm EX-31.1 15109
3 EXHIBIT 31.2 exhibit31cfo.htm EX-31.2 14709
4 EXHIBIT 32.1 exhibit32ceo.htm EX-32.1 6274
5 EXHIBIT 32.2 exhibit32cfo.htm EX-32.2 6805
  Complete submission text file 0001008848-10-000019.txt   2173637

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT -101.INS acor-20100630.xml EX-101.INS 222346
7 XBRL SCHEMA EXHIBIT 101.SCH acor-20100630.xsd EX-101.SCH 9781
8 XBRL CALCULATION LINK BASE acor-20100630_cal.xml EX-101.CAL 43279
9 XBRL LABEL LINK BASE acor-20100630_lab.xml EX-101.LAB 135007
10 XBRL PRESENTATION LINK BASE acor-20100630_pre.xml EX-101.PRE 79804
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 101002538
SIC: 2836 Biological Products, (No Diagnostic Substances)